BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/20/2020 2:28:50 AM | Browse: 784 | Download: 1428
 |
Received |
|
2020-03-12 22:18 |
|
Peer-Review Started |
|
2020-03-02 04:22 |
|
First Decision by Editorial Office Director |
|
2020-04-22 21:05 |
|
Return for Revision |
|
2020-04-22 22:02 |
|
Revised |
|
2020-04-28 02:23 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-05-29 06:50 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-05-30 22:05 |
|
Articles in Press |
|
2020-05-30 22:05 |
|
Edit the Manuscript by Language Editor |
|
2020-06-05 16:52 |
|
Typeset the Manuscript |
|
2020-07-17 05:57 |
|
Publish the Manuscript Online |
|
2020-07-20 02:28 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biochemistry & Molecular Biology |
| Manuscript Type |
Minireviews |
| Article Title |
Why natural killer cells in triple negative breast cancer?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mustafa Abdel-Latif and Rana Ahmed Youness |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Rana Ahmed Youness, BSc, PhD, Lecturer, Research Associate, Pharmaceutical Biology Department, Faculty of Pharmacy and Biotechnology, German University in Cairo, El Tagamoa El Khames, Cairo 11835, Egypt. rana.youness21@gmail.com |
| Key Words |
Triple negative breast cancer; Natural killer cells; Immne checkpoint blockades; Programmed death-ligand 1; Cytotoxic T-lymphocyte-associated protein 4; Natural killer lectin-like group 2 member D |
| Core Tip |
Triple-negative breast cancer (TNBC) patients are the least fortunate in terms of prognosis and conventional therapeutic approaches. In this review, we are focusing on the bright side of the story; TNBC patients are recently considered the patients of choice when it comes to immunotherapy. We are shedding the light onto the immune-checkpoint blockades such as programmed death-ligand 1 inhibitors and its recently discovered side-effects and resistance cases that started to appear in the clinics. In such context, we tried to drive the researchers' attention to a very potential weapon known as the innate immune system and its native soldiers which are the natural killer cells. |
| Publish Date |
2020-07-20 02:28 |
| Citation |
Abdel-Latif M, Youness RA. Why natural killer cells in triple negative breast cancer? World J Clin Oncol 2020; 11(7): 464-476 |
| URL |
https://www.wjgnet.com/2218-4333/full/v11/i7/464.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v11.i7.464 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
